Science launches PRIMA for geographic atrophy in Europe
PRIMA is the first BCI device with CE mark for form vision restoration, restoring reading ability in AMD patients.
See the latest news and media coverage for Science. We track all announcements, press releases, and industry mentions in real time, all in one place.
Last updated
In short: Science launched its PRIMA retinal implant in Europe after receiving CE mark approval to restore vision in patients with macular degeneration.
PRIMA is the first BCI device with CE mark for form vision restoration, restoring reading ability in AMD patients.
The designations cover advanced geographic atrophy and Stargardt disease, expediting regulatory review for these blindness treatments.
José-Alain Sahel, M.D., discusses the historic PRIMA clinical trial results published in NEJM, where over 80% of patients could read letters and words.
This enables commercialization of the PRIMA BCI retinal implant and expansion of clinical trials for other retinal diseases.
None...
Science Corporation, a startup developing novel brain-computer interfaces (BCI), won approval from Europe's medical device regulator to begin selling a device that restores vision lost...
Science Corporation, the startup from former Neuralink president and co-founder Max Hodak, has enlisted a top neurobiologist to lead the first U.S.
Science Corp., a brain implant startup led by Neuralink co-founder Max Hodak, raised $230 million in Series C funding at a $1.5 billion valuation. Why...
Track Science and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.